About 5 results

Dr. Chiaka Anumudu at University of Ibadan previously identified 54 human proteins as potential biomarkers for schistosomiasis and bladder pathologies. Through WIPO Re:Search, Dr. Anumudu shared 60 urine samples with Dr. Horacio Bach at the University of British Columbia to support biomarker identification and validation. Upon identification of the biomarker(s), recombinant antibodies will be generated in Dr. Bach’s laboratory to develop a serological test for fast diagnosis.

A researcher from Griffith University will perform activity-guided fractionation on natural product extracts previously demonstrated by a University of Ibadan researcher to have activity against S. mansoni and S. haematobium or their intermediate snail hosts.

Dr. Hu developed a dipstick diagnostic for S. japonicum, a species of the parasitic flatworm commonly found in the Far East. BVGH connected Dr. Hu with Dr. Alexander Odaibo at the University of Ibadan, who used samples from Schistosoma-infected patients to assess the dipstick’s ability to detect S. mansoni and S. haematobium, the prevailing species in Africa.

A University of Ibadan researcher collaborated with an NIPD researcher to work on serum samples from Nigerian schistosomiasis patients. The NIPD researcher hosted a post-doctoral scientist from Nigeria to identify potential Schistosoma mansoni and S. haematobium antigens to incorporate into a schistosomiasis rapid diagnostic.

A UBC researcher elucidated the structures of ~10 natural products previously demonstrated by a University of Ibadan researcher to have anti-malarial or anti-tuberculosis activities.